Theranos Investor Conference Presentation Deck

Lymphocyte Subset: Capillary Bias Summary Capillary miniLab vs Venous Capillary miniLab vs Venous miniLab BD TBNK Analyte Total T cells CD4+ T cells CD8+ T cells B cells NK cells Lymphocytes Passing-Bablok regression This technology has not been cleared or approved by the FDA and is not for sale in the United States. R² 0.93 0.94 0.92 0.93 0.84 0.88 Median Bias 3.7% 4.2% 5.9% 6.1% 9.6% 4.3% R² 0.92 0.93 0.94 0.92 0.90 0.89 Median Bias 4.9% 4.6% 6.4% 5.6% 8.9% 6.8% theranos 71

View entire presentation